Zobrazeno 1 - 10
of 96
pro vyhledávání: '"Cristina Vedovati"'
Autor:
Setareh Salehi Omran, Liqi Shu, Allison Chang, Neal S. Parikh, Adeel S. Zubair, Alexis N. Simpkins, Mirjam R. Heldner, Arsany Hakim, Sami Al Kasab, Thanh Nguyen, Piers Klein, Eric D. Goldstein, Maria Cristina Vedovati, Maurizio Paciaroni, David S. Liebeskind, Shadi Yaghi, Shawna Cutting
Publikováno v:
Journal of Stroke, Vol 25, Iss 2, Pp 291-298 (2023)
Background and Purpose Vessel recanalization after cerebral venous thrombosis (CVT) is associated with favorable outcomes and lower mortality. Several studies examined the timing and predictors of recanalization after CVT with mixed results. We aimed
Externí odkaz:
https://doaj.org/article/b074e7f7378e49cab8d756129bb52d68
Autor:
Piers Klein, Liqi Shu, Thanh N. Nguyen, James E. Siegler, Setareh Salehi Omran, Alexis N. Simpkins, Mirjam Heldner, Adam de Havenon, Hugo J. Aparicio, Mohamad Abdalkader, Marios Psychogios, Maria Cristina Vedovati, Maurizio Paciaroni, Rascha von Martial, David S. Liebeskind, Diana Aguiar de Sousa, Jonathan M. Coutinho, Shadi Yaghi
Publikováno v:
Journal of Stroke, Vol 24, Iss 3, Pp 404-416 (2022)
Background We identified risk factors, derived and validated a prognostic score for poor neurological outcome and death for use in cerebral venous thrombosis (CVT). Methods We performed an international multicenter retrospective study including conse
Externí odkaz:
https://doaj.org/article/f59e4069e7f44cd7828c7c6b6beb5317
Autor:
Flavia K. Borges, MD, PhD, Tej Sheth, MD, Ameen Patel, MD, Maura Marcucci, MD, MSc, Terence Yung, MD, Thomas Langer, MD, Carolina Alboim, MD, Carisi Anne Polanczyk, MD, ScD, Federico Germini, MD, Andre Ferreira Azeredo-da-Silva, MD, ScD, Erin Sloan, MD, Kendeep Kaila, MD, Ron Ree, MD, Alessandra Bertoletti, MD, Maria Cristina Vedovati, MD, Antonio Galzerano, MD, Jessica Spence, MD, P.J. Devereaux, MD, PhD
Publikováno v:
CJC Open, Vol 2, Iss 6, Pp 577-584 (2020)
Background: Physicians commonly judge whether a myocardial infarction (MI) is type 1 (thrombotic) vs type 2 (supply/demand mismatch) based on clinical information. Little is known about the accuracy of physicians’ clinical judgement in this regard.
Externí odkaz:
https://doaj.org/article/c0f78cd7c00549c49df0cac210200c7d
Autor:
Michela Giustozzi, Giancarlo Agnelli, Silvia Quattrocchi, Monica Acciarresi, Andrea Alberti, Valeria Caso, Maria Cristina Vedovati, Michele Venti, Maurizio Paciaroni
Publikováno v:
Cerebrovascular Diseases Extra, Vol 10, Iss 2, Pp 44-49 (2020)
Introduction and Objective: Even though the introduction of less cumbersome anticoagulant agents has improved, the rates ofoverall anticoagulant treatment in eligible patients with atrial fibrillation (AF) remain to be defined. We aimed to assess the
Externí odkaz:
https://doaj.org/article/613d89fdd31b4be6b02e40e21dc82b26
Autor:
Maria Cristina Vedovati, Michela Giustozzi, Andrés Munoz, Laurent Bertoletti, Alexander T. Cohen, Frederikus A. Klok, Jean M. Connors, Rupert Bauersachs, Benjamin Brenner, Mauro Campanini, Cecilia Becattini, Giancarlo Agnelli
Publikováno v:
European Journal of Internal Medicine. 112:29-36
Publikováno v:
Internal and Emergency Medicine. 18:863-877
Venous thromboembolism (VTE) is common in patients with coronavirus disease-2019 (COVID-19). The optimal heparin regimen remains unknown and should balance thromboembolic and bleeding risks. The aim of this study was to evaluate the efficacy and safe
Publikováno v:
TH Open, Vol 03, Iss 02, Pp e157-e164 (2019)
Abstract Background Valvular heart disease (VHD) and atrial fibrillation (AF) often coexist. Aim We investigated whether type 2 VHD (other than moderate-severe rheumatic mitral stenosis or mechanical heart valve) influences the prescription of an
Externí odkaz:
https://doaj.org/article/a9f3322ebe5246e6a84bf2b123b0bd0e
Autor:
Michela Giustozzi, Maria Cristina Vedovati, Melina Verso, Luca Scrucca, Serenella Conti, Paolo Verdecchia, Giulio Bogliari, Lucia Pierpaoli, Giancarlo Agnelli, Cecilia Becattini
Publikováno v:
Data in Brief, Vol 23, Iss , Pp - (2019)
The data presented in this article are related to the research article entitled “Patients aged 90 years or older with atrial fibrillation treated with oral anticoagulants: A multicentre observational study” [1]. This article unveils original data
Externí odkaz:
https://doaj.org/article/4eab1064ab3c49f5a7dbfdbbff16c099
Autor:
Setareh Salehi Omran, Liqi Shu, Allison Chang, Neal S Parikh, Adeel Zubair, Alexis Simpkins, Mirjam Heldner, Arsany Hakim, Sami Al Kasab, Thanh Nguyen, Piers Klein, Eric Goldstein, Maria Cristina Vedovati, Maurizio Paciaroni, David S Liebeskind, Shadi Yaghi, Shawna M Cutting
Publikováno v:
Stroke. 54
Background and Purpose: Recanalization after cerebral venous thrombosis (CVT) is poorly understood. We aimed to investigate predictors and timing of recanalization in a large, international cohort of patients with CVT. Materials and Methods: We used
Autor:
Maria Giulia Mosconi, Giorgio Maraziti, Maurizio Paciaroni, Michela Giustozzi, Maria Cristina Vedovati, Giulio Bogliari, Chiara Urbini, Laura Traballi, Valeria Caso
Background: The efficacy and safety profiles of nonrecommended direct oral anticoagulant (DOAC) doses in patients with nonvalvular atrial fibrillation (NVAF) are still undefined. Summary: We searched for randomized controlled trials and observational
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::764d3be4097ba038c1fc9f95806fff85
https://hdl.handle.net/11391/1542637
https://hdl.handle.net/11391/1542637